Viewing Study NCT04667351


Ignite Creation Date: 2025-12-24 @ 11:48 PM
Ignite Modification Date: 2026-04-23 @ 4:22 AM
Study NCT ID: NCT04667351
Status: UNKNOWN
Last Update Posted: 2020-12-14
First Post: 2020-12-09
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: HAIC of Oxaliplatin, and 2400 mg/m² 5-fu vs HAIC of Oxaliplatin, and 1200 mg/m² 5-fu for Unresectable HCC: a Randomised Phase 3 Non-inferiority Trial
Sponsor: Sun Yat-sen University
Organization:

Organization Data

Organization:
Class: OTHER
Study ID: SH-1
Study Type: None
Study Domain: None
Study Link: None
Lead Sponsor:
Lead Sponsor Class: OTHER
Responsible Party:
Responsible Party Title:
Responsible Party Type: PRINCIPAL_INVESTIGATOR
Responsible Party Affiliation:
Old Name: None
Old Organization: None

Collaborators

Collaborators

Name Class View
None OTHER View
None OTHER_GOV View